Apollomics, Inc.
- APLM
- NASDAQ
- Biotechnology
- Oncology Therapeutics
- Cancer Drug Development
$21.10
Today −0.00%Quote Oct 16, 2026, 08:00 PM UTC
−6.35%over the last month
Max drawdown −15.8%From 1-month high −15.4%3 months +11.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$46.3M
Quote Oct 16
Next earnings
Apr 1
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$20.50
2.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about APLMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
14